| 1. |
- Andersson, J. C., et al.
(författare)
-
Modeling the Äspö Pillar stability experiment
- 2010
-
Ingår i: Rock Mechanics in Civil and Environmental Engineering - Proceedings of the European Rock Mechanics Symposium, EUROCK 2010. - 9780415586542 ; , s. 787-790
-
Konferensbidrag (refereegranskat)abstract
- This paper presents results of the 1st stages ofTaskAof the Decovalex 2011 project, the numerical modeling of the Äspö Pillar Stability experiment performed by the Äspö Hard Rock Laboratory of the Swedish Nuclear Fuel and Waste Management Company (SKB). The objective is to perform back calculation of the Äspö pillar behavior using state of the art numerical modeling techniques for the material behavior. The work is divided into three stages and it is the first stage of thework that will be presented in this paper. Seven international teams from six different countries participated in the task and contributed to the results presented in this paper, concerning back calculation of uniaxial and triaxial compressive core testing and elastic back calculation of the stress path for excavation-induced stresses. The results are useful for understanding the occurrence of spalling in the upper part of the pillar during excavation and the stress path modeling gives the first approximation of the yielding strength of the pillar. The calculated results agree well with observations measured during experiment.
|
|
| 2. |
- Dehghani, F., et al.
(författare)
-
Inhibition of microglial and astrocytic inflammatory responses by the immunosuppressant mycophenolate mofetil
- 2010
-
Ingår i: Neuropathology and Applied Neurobiology. - : Wiley. - 0305-1846 .- 1365-2990. ; 36:7, s. 598-611
-
Tidskriftsartikel (refereegranskat)abstract
- Aims: Nucleotide depletion induced by the immunosuppressant mycophenolate mofetil (MMF) has been shown to exert neuroprotective effects. It remains unclear whether nucleotide depletion directly counteracts neuronal demise or whether it inhibits microglial or astrocytic activation, thereby resulting in indirect neuroprotection. Methods: Effects of MMF on isolated microglial cells, astrocyte/microglial cell co-cultures and isolated hippocampal neurones were analysed by immunocytochemistry, quantitative morphometry, and elisa. Results: We found that: (i) MMF suppressed lipopolysaccharide-induced microglial secretion of interleukin-1 beta, tumour necrosis factor-alpha and nitric oxide; (ii) MMF suppressed lipopolysaccharide-induced astrocytic production of tumour necrosis factor-alpha but not of nitric oxide; (iii) MMF strongly inhibited proliferation of both microglial cells and astrocytes; (iv) MMF did not protect isolated hippocampal neurones from excitotoxic injury; and (v) effects of MMF on glial cells were reversed after treatment with guanosine. Conclusions: Nucleotide depletion induced by MMF inhibits microglial and astrocytic activation. Microglial and astrocytic proliferation is suppressed by MMF-induced inhibition of the salvage pathway enzyme inosine monophosphate dehydrogenase. The previously observed neuroprotection after MMF treatment seems to be indirectly mediated, making this compound an interesting immunosuppressant in the treatment of acute central nervous system lesions.
|
|
